Article

Six Month Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine

2021-07-28

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> BNT162b2 is a lipid nanoparticle-formulated, nucleoside-modified RNA vaccine encoding a prefusion-stabilized, membrane-anchored SARS-CoV-2 full-length spike protein. BNT162b2 is highly efficacious against COVID-19 and is currently authorized for emergency use or conditional approval worldwide. At the time of authorization, data beyond 2 months post-vaccination were unavailab...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 51389de3-ea72-58fd-963c-62c32517cc85
DOI: 10.1101/2021.07.28.21261159

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Six Month Safety and Efficacy of the BNT162b2 mRNA COVID-19 VaccineDOI 10.1101/2021.07.28.21261159Read

Phase 1/2 Study to Describe the Safety and Immunogenicity of a COVID-19 RNA Vaccine Candidate (BNT162b1) in Adults 18 to 55 Years of Age: Interim ReportSemantic proximity Read

Concurrent human antibody and T<sub>H</sub>1 type T-cell responses elicited by a COVID-19 RNA vaccineSemantic proximity Read

BNT162b2 induces SARS-CoV-2-neutralising antibodies and T cells in humansSemantic proximity Read

Immunogenicity and safety of DS-5670d, an mRNA-based COVID-19 vaccine targeting omicron XBB.1.5: Results from a phase 3, randomized, active-controlled study in adults and children aged ≥12 yearsSemantic proximity Read

Immunogenicity of BNT162b2 COVID-19 vaccine in New Zealand adultsSemantic proximity Read

Preliminary Efficacy of the NVX-CoV2373 Covid-19 Vaccine Against the B.1.351 VariantSemantic proximity Read

Immunogenicity and Safety of BNT162b2 mRNA Vaccine in Chinese Adults: A Randomized Clinical TrialSemantic proximity Read

Comprehensive assessment of humoral response after Pfizer BNT162b2 mRNA Covid-19 vaccination: a three-case seriesSemantic proximity Read

Real-world effectiveness and non-inferiority evaluation and comparison of mRNA- and protein-based COVID-19 vaccines: a randomized study protocol (BEEHIVE)Semantic proximity Read

Immunogenicity and Safety of COVID-19 Booster Vaccination: A Real-World Clinical Trial to Identify the Best Vaccination StratagySemantic proximity Read

Immune Response and Clinical Outcomes of BNT162b2 and mRNA1273 Fourth Dose COVID-19 Vaccines; Three Months Follow-upSemantic proximity Read

Efficacy of the NVX-CoV2373 Covid-19 Vaccine Against the B.1.1.7 VariantSemantic proximity Read